Chemoradiotherapy after gemcitabine plus erlotinib in patients with locally advanced pancreatic cancer.

Eunji Kim, Kyubo Kim, Eui Kyu Chie, Do Youn Oh, Young Tae KimPubMed 2019

Abstract

Intensive treatment with gemcitabine-based CRT, high RT dose, and maintenance chemotherapy may improve survival outcomes in locally advanced pancreatic cancer patients receiving neoadjuvant gemcitabine/erlotinib.
BibTeX
@inproceedings{kim2019chemoradiotherapy,
  author = {Eunji Kim and Kyubo Kim and Eui Kyu Chie and Do Youn Oh and Young Tae Kim},
  title = {{Chemoradiotherapy after gemcitabine plus erlotinib in patients with locally advanced pancreatic cancer.}},
  booktitle = {PubMed},
  year = {2019},
}

Loading related content...

Figure